NCT02883062 2026-04-13
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Washington University School of Medicine
Eastern Cooperative Oncology Group
Stanford University
Cedars-Sinai Medical Center
Ohio State University Comprehensive Cancer Center
Haukeland University Hospital
Northwestern University
University of Virginia